ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,174.37
0.02%
Dow Jones
42,544.22
-0.07%
Gold vs US Dollar
2,638.14
0.53%
Brent Oil
74.98
1.52%
Bitcoin
96,197.79
1.92%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Bristol Myers Squibb Co (BMY) Share Price

BMY Bristol Myers Squibb Co

56.56
0.00 (0.00%)
Pre Market
Last Updated: 09:16:27
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Bristol Myers Squibb Co NYSE:BMY New York Stock Exchange Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 56.56 0.00 0.00 0.00 0.00  152 09:16:27   
*quotes are delayed by at least 20 minutes
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 45.01B 8.03B 3.9568 14.29 114.71B
 Type  Size  Price  Time  Units 
 9 1 56.70 09:11:17 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore BMY News
27/12/202422:37BWU.S. Food and Drug Administration Approves Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo® (nivolumab) Indications1,2
23/12/202411:59BWBristol Myers Squibb Announces Positive Topline Results from Two Pivotal Phase 3 Trials Evaluating Sotyktu (deucravacitinib) in Adults with Psoriatic Arthritis
23/12/202411:45BWBristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer
19/12/202411:59BWBristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025
11/12/202421:17BWBristol Myers Squibb Announces Dividend Increase
09/12/202422:45BWBristol Myers Squibb Highlights Progress of Cell Therapy Portfolio at ASH 2024 with Long-Term Survival Data and Results from Expanding Pipeline
26/11/202411:59BWBristol Myers Squibb to Participate in Citi’s 2024 Global Healthcare Conference
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
19/12/202422:42PBB*** Bloomsbury Publishing ***673
04/02/202212:48PBBBLOOMSBURY PRICE EXPLOSION . HARRY POTTER 4:1 SHARE SPLIT.48
21/07/202007:28PBBRAINMAKER'S BLOOMSBURY PUBLISHING THREAD(BMY)-115.5p-FAILING TO PRICE GROWTH?1,085
18/02/201109:05PBBJonathan Strange better than Harry Potter277
27/03/200710:20PBBOnly worth 43p on fundamentals3
24/10/200512:23PBBBloomsbury - a buy ahead of Harry Potter Book on FRIDAY?? yyyyyeeeeessssss!!!!57
23/12/200316:22PBBBloomsbury - Time to short?7
23/06/200315:56PBBBloomsbury - Up sharfly on news on next book release in June/July -39
15/07/200213:16PBBBloomsbury Results42
27/01/200216:32PBBHarry Potter in China1
Data Downloads for BMY

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Bristol Myers Squibb Co Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads